1. Jacobsson S, Hollender L. Treatment and prognosis of diffuse sclerosing osteomyelitis (DSO) of the mandible. Oral Surg Oral Med Oral Pathol. 1980;49:7-14.

https://doi.org/10.1016/0030-4220(80)90024-9

PMid:6927942 

2. Van Merkesteyn JP, Groot RH, Bras J, Bakker DJ. Diffuse sclerosing osteomyelitis of the mandible: clinical radiographic and histologic findings in twenty-seven patients. J Oral Maxillofac Surg. 1988;46:825-9.

https://doi.org/10.1016/0278-2391(88)90042-0

PMid:3171740 

3. Compeyrot-Lacassagne S, Rosenberg AM, Babyn P, Laxer RM. Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children. J Rheumatol. 2007;34:1585-9.

PMid:17611964

4. Mari A, Morla A, Melero M, Schiavone R, Rodriguez J. Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: a novel approach with anti-TNF therapy. Systematic review. J Craniomaxillofac Surg. 2014;42:1990-6.

https://doi.org/10.1016/j.jcms.2014.09.004

PMid:25441866 

5. Otto S, Troeltzsch M, Burian E, Mahaini S, Probst F, Pautke C, et al. Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis. J Craniomaxillofac Surg. 2015;43:1837-42.

https://doi.org/10.1016/j.jcms.2015.08.028

PMid:26421465 

6. Montonen M, Kalso E, Pylkkaren L, Lindstrorm BM, Lindqvist C. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible. Int J Oral Maxillofac Surg. 2001;30:313-7.

https://doi.org/10.1054/ijom.2001.0061

PMid:11518354 

7. Suei Y, Taguchi A, Tanimoto K. Radiographic evaluation of possible etiology of diffuse sclerosing osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:571-7.

https://doi.org/10.1016/S1079-2104(97)90275-4

PMid:9394391 

8. Schuknecht BF, Carls FR, Valavanis A, Sailer HF. Mandibular osteomyelitis: evaluation and staging in 18 patients, using magnetic resonance imaging, computed tomography and conventional radiographs. J Craniomaxillofac Surg. 1997;25:24-33.

https://doi.org/10.1016/S1010-5182(97)80021-2

PMid:9083398 

9. Fayers P, Bottomley A, Group EQoL, Quality of Life U. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38 Suppl 4:S125-33.

https://doi.org/10.1016/S0959-8049(01)00448-8

PMid:11858978 

10. Mittal H, John MT, Sekulic S, Theis-Mahon N, Rener-Sitar K. Patient-Reported Outcome Measures for Adult Dental Patients: A Systematic Review. J Evid Based Dent Pract. 2019;19:53-70.

https://doi.org/10.1016/j.jebdp.2018.10.005

PMid:30926102 PMCid:PMC6442935

11. Douglas-de-Oliveira DW, Chen KJ. Patient-reported measures outcomes: modern evaluation of oral health. BMC Oral Health. 2023;23:498.

https://doi.org/10.1186/s12903-023-03219-0

PMid:37464376 PMCid:PMC10355069

12. Gilchrist F, Rodd H, Deery C, Marshman Z. Assessment of the quality of measures of child oral health-related quality of life. BMC Oral Health. 2014;14:40.

https://doi.org/10.1186/1472-6831-14-40

PMid:24758535 PMCid:PMC4021173

13. O'Kelly J, Bartsch R, Kossack N, Borchert J, Pignot M, Hadji P. Real-world effectiveness of osteoporosis treatments in Germany. Arch Osteoporos. 2022;17:119.

https://doi.org/10.1007/s11657-022-01156-z

PMid:36044096 PMCid:PMC9512727

14. Kimmel DB. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res. 2007;86:1022-33.

https://doi.org/10.1177/154405910708601102

PMid:17959891 

15. Otto S, Hafner S, Mast G, Tischer T, Volkmer E, Schieker M, et al. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?. J Oral Maxillofac Surg. 2010;68:1158-61.

https://doi.org/10.1016/j.joms.2009.07.079

PMid:20138420 

16. Jia K, Li T, An J. Is Operative Management Effective for Non-Bacterial Diffuse Sclerosing Osteomyelitis of the Mandible?. J Oral Maxillofac Surg. 2021;79:2292-8.

https://doi.org/10.1016/j.joms.2021.06.024

PMid:34339621 

17. Jones J, Amess TR, Robinson PD. Treatment of chronic sclerosing osteomyelitis of the mandible with calcitonin: a report of two cases. Br J Oral Maxillofac Surg. 2005;43:173-6.

https://doi.org/10.1016/j.bjoms.2004.10.002

PMid:15749221 

18. Groot RH, van Merkesteyn JP, van Soest JJ, Bras J. Diffuse sclerosing osteomyelitis (chronic tendoperiostitis) of the mandible. An 11-year follow-up report. Oral Surg Oral Med Oral Pathol. 1992;74:557-60.

https://doi.org/10.1016/0030-4220(92)90342-N

PMid:1437057 

19. Kuijpers SC, de Jong E, Hamdy NA, van Merkesteyn JP. Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. J Craniomaxillofac Surg. 2011;39:65-8.

https://doi.org/10.1016/j.jcms.2010.03.014

PMid:20427193 

20. van de Meent MM, Appelman-Dijkstra NM, Wetselaar-Glas MJM, Pichardo SEC, van Merkesteyn JPR. Bisphosphonate therapy in chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible: Retrospective case series. J Craniomaxillofac Surg. 2022;50:599-604.

https://doi.org/10.1016/j.jcms.2022.05.011

PMid:35768318 

21. Matharu J, Taylor H, Sproat C, Kwok J, Brown J, Patel V. Diffuse sclerosing osteomyelitis: a case series and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129:437-46.

https://doi.org/10.1016/j.oooo.2019.11.010

PMid:32102763 

22. Cook KF, Jensen SE, Schalet BD, Beaumont JL, Amtmann D, Czajkowski S, et al. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol. 2016;73:89-102.

https://doi.org/10.1016/j.jclinepi.2015.08.038

PMid:26952842 PMCid:PMC5131708

23. Lennmyr EB, Karlsson K, Abrahamsson M, Ebrahim F, Lubking A, Hoglund M, et al. Introducing patient-reported outcome in the acute leukemia quality registries in Sweden. Eur J Haematol. 2020;104:571-80.

https://doi.org/10.1111/ejh.13399

PMid:32080889 

24. Vijayakumar G, Blank AT. Patient-reported outcome tools in musculoskeletal oncology. J Surg Oncol. 2023;128:418-24.

https://doi.org/10.1002/jso.27386

PMid:37537983 

25. Beecher D, James P, Browne J, Di Blasi Z, Harding M, Whelton H. Dental patient reported outcome and oral health-related quality of life measures: protocol for a systematic evidence map of reviews. BDJ Open. 2021;7:6.

https://doi.org/10.1038/s41405-021-00065-6

PMid:33510135 PMCid:PMC7844023

26. Nelson E, Conger B, Douglass R, Gephart D, Kirk J, Page R, et al. Functional health status levels of primary care patients. JAMA. 1983;249:3331-8.

https://doi.org/10.1001/jama.1983.03330480037027

PMid:6602226 

27. Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, et al. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Qual Life Res. 2013;22:1927-41.

https://doi.org/10.1007/s11136-012-0325-1

PMid:23188134 

28. Oghli I, List T, Su N, Haggman-Henrikson B. The impact of oro-facial pain conditions on oral health-related quality of life: A systematic review. J Oral Rehabil. 2020;47:1052-64.

https://doi.org/10.1111/joor.12994

PMid:32415993